These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1362105)

  • 1. The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro.
    Devalia JL; Sapsford RJ; Rusznak C; Toumbis MJ; Davies RJ
    Pulm Pharmacol; 1992 Dec; 5(4):257-63. PubMed ID: 1362105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.
    Kanthakumar K; Cundell DR; Johnson M; Wills PJ; Taylor GW; Cole PJ; Wilson R
    Br J Pharmacol; 1994 Jun; 112(2):493-8. PubMed ID: 7915610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
    Yang Q; Battistini B; Pelletier S; Sirois P
    Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of albuterol enantiomers on ciliary beat frequency in ovine tracheal epithelial cells.
    Frohock JI; Wijkstrom-Frei C; Salathe M
    J Appl Physiol (1985); 2002 Jun; 92(6):2396-402. PubMed ID: 12015353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
    Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
    Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of salmeterol.
    Johnson M; Butchers PR; Coleman RA; Nials AT; Strong P; Sumner MJ; Vardey CJ; Whelan CJ
    Life Sci; 1993; 52(26):2131-43. PubMed ID: 8099695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
    Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effect of salmeterol and salbutamol in normal subjects.
    Spring J; Clague J; Ind PW
    Br J Clin Pharmacol; 1992 Feb; 33(2):139-41. PubMed ID: 1348000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    Chong LK; Cooper E; Vardey CJ; Peachell PT
    Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro.
    Källström BL; Sjöberg J; Waldeck B
    Br J Pharmacol; 1994 Nov; 113(3):687-92. PubMed ID: 7858856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal mucociliary clearance and salmeterol.
    Tay HL; Armoogum N; Tan LK
    Clin Otolaryngol Allied Sci; 1997 Feb; 22(1):68-70. PubMed ID: 9088685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
    Bennett JA; Tattersfield AE
    Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway effects of salmeterol in healthy individuals.
    Bergendal A; Johansson A; Bake B; Lötvall J; Skoogh BE; Löfdahl CG
    Pulm Pharmacol; 1995 Dec; 8(6):283-8. PubMed ID: 8819183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.
    Whelan CJ; Johnson M
    Br J Pharmacol; 1992 Apr; 105(4):831-8. PubMed ID: 1354536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of ciliary motility mediated by atypical beta-adrenoceptor in canine bronchial epithelium.
    Tamaoki J; Chiyotani A; Sakai N; Konno K
    Life Sci; 1993; 53(20):1509-15. PubMed ID: 8105356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea pig trachea with or without epithelium.
    Ullman A; Bergendal A; Lindén A; Waldeck B; Skoogh BE; Löfdahl CG
    Allergy; 1992 Aug; 47(4 Pt 2):384-7. PubMed ID: 1360770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory actions of salmeterol on human airway macrophages and blood monocytes.
    Baker AJ; Palmer J; Johnson M; Fuller RW
    Eur J Pharmacol; 1994 Nov; 264(3):301-6. PubMed ID: 7698169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta2-adrenoceptor agonists reduce the decline of rat diaphragm twitch force during severe hypoxia.
    van der Heijden HF; Heunks LM; Folgering H; van Herwaarden CL; Dekhuijzen PN
    Am J Physiol; 1999 Mar; 276(3):L474-80. PubMed ID: 10070112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.